NCT01211847View on ClinicalTrials.gov

Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

September 30, 2011

Study Completion Date

December 31, 2011

Conditions
HypertriglyceridemiaDyslipidemia
Interventions
DRUG

Diazoxide Choline Controlled-Release Tablet

DCCR 290 mg once a day for 126 days

DRUG

Placebo

Placebo matching DCCR

Sponsors

Collaborators (1)

Medpace, Inc.
All Listed Sponsors
collaborator

Medpace, Inc.

INDUSTRY

lead

Essentialis, Inc.

INDUSTRY